mRNA |
MPS-1-IN-1 |
GDSC1000 |
pan-cancer |
AAC |
0.093 |
0.003 |
mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
-0.16 |
0.003 |
mRNA |
A-770041 |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
0.003 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.003 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.004 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.004 |
mRNA |
Vorinostat |
GDSC1000 |
pan-cancer |
AAC |
0.085 |
0.005 |
mRNA |
Platin |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.005 |
mRNA |
BRD-K55116708 |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.005 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.005 |